Alzheimer's disease (AD) is defined by the concurrence of abnormal aggregates composed of phosphorylated tau protein and of abnormal cellular changes including neurite degeneration, loss of neurons, and loss of cognitive functions. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.